{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:40:50Z","timestamp":1792662050252,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and hypothesis<\/jats:title>\n                    <jats:p>Microvascular inflammation (MVI), a histological hallmark of antibody-mediated rejection, is typically associated with donor-specific antibodies (DSA), but can also occur in their absence. Evidence implicates natural killer (NK) cells in DSA-negative MVI, although the mechanisms underlying their activation remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 165 kidney transplant biopsies, regarding biopsy-based diagnostic categories as competing events: (1) MVI\u00a0+\u00a0DSA+ (n\u00a0=\u00a091), (2) MVI\u00a0+\u00a0DSA- (n\u00a0=\u00a035), and (3) MVI\u00a0-\u00a0DSA+ (n = 39). Recipients and donors were genotyped for killer-cell immunoglobulin-like receptor (KIR) and Human Leukocyte Antigen (HLA) to assess \u201cmissing self\u201d-the absence of donor HLA ligands for recipient inhibitory KIR. We also tested the moderating effect of NK cell functional polymorphisms in FCGR3A (V\/F158), KLRK1 (LNK\/HNK), KLRC2 (wt\/del), and rs9916629. We used cumulative incidence functions and cause-specific Cox regression models to examine the association of genetic variants and the incidence of the competing biopsy-based diagnostic categories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The presence of missing self was associated with a lower hazard of MVI\u00a0-\u00a0DSA+ occurrence (hazard ratio [HR] 0.37, 95% confidence interval [CI]: 0.16\u20130.84, P\u00a0= 0.017); (adjusted HR 0.42, 95% CI: 0.18-1.00, P\u00a0=\u00a00.051), while a trend suggested a higher incidence of MVI\u00a0+\u00a0DSA- diagnosis when missing self was present (HR: 1.43, 95% CI: 0.71\u20132.89, P\u00a0=\u00a00.313; adjusted HR 1.53, 95% CI: 0.72\u20133.25, P\u00a0=\u00a00.269). None of NK high functional polymorphisms had a moderating effect on the relation between missing self and biopsy-based diagnostic categories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that missing self is unlikely to increase the probability of MVI per se. On the other hand, missing self decreases the likelihood of biopsy findings being free of MVI in patients who develop DSA. Given the selected, biopsy-based cohort and the absence of an MVI\u00a0-\u00a0DSA- comparison group, these findings are exploratory and require validation in larger, prospectively defined cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfag231","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:41:03Z","timestamp":1791286863000},"source":"Crossref","is-referenced-by-count":0,"title":["NK cell missing self in microvascular inflammation with and without donor-specific antibodies"],"prefix":"10.1093","author":[{"given":"Benedetta","family":"Mord\u00e0","sequence":"first","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9-Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]},{"name":"Nephrology Unit, University Hospital of Parma , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9227-8017","authenticated-orcid":false,"given":"Aylin","family":"Akifova","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9-Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-9132","authenticated-orcid":false,"given":"Matthias","family":"Diebold","sequence":"additional","affiliation":[{"name":"Transplant Immunology & Nephrology, University Hospital Basel , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Lachmann","sequence":"additional","affiliation":[{"name":"Center for Tumor Medicine, Histocompatibility & Immunogenetics Laboratory, Charit\u00e9-Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareen","family":"Pigorsch","sequence":"additional","affiliation":[{"name":"Institute of Biometry and Clinical Epidemiology, Charit\u00e9-Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Vietzen","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Puchhammer-St\u00f6ckl","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M","family":"K\u00fchner","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Berger","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Lassahn","sequence":"additional","affiliation":[{"name":"Center for Tumor Medicine, Histocompatibility & Immunogenetics Laboratory, Charit\u00e9-Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Stauch","sequence":"additional","affiliation":[{"name":"Center for Tumor Medicine, Histocompatibility & Immunogenetics Laboratory, Charit\u00e9-Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilgin","family":"Osmanodja","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9-Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Maggiore","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg A","family":"B\u00f6hmig","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7929-5942","authenticated-orcid":false,"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9-Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2026102205030484200_bib1","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Kidney transplantation compared with dialysis in clinically relevant outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transplant"},{"key":"2026102205030484200_bib2","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"2026102205030484200_bib3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"key":"2026102205030484200_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa2408835","article-title":"Microvascular inflammation of kidney allografts and clinical outcomes","volume":"392","author":"Sablik","year":"2025","journal-title":"N Engl J Med"},{"key":"2026102205030484200_bib5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ajt.2022.12.018","article-title":"Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: an orphan category in Banff classification with cytotoxic T and natural killer cell infiltration","volume":"23","author":"Buxeda","year":"2023","journal-title":"Am J Transplant"},{"key":"2026102205030484200_bib6","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1111\/ajt.16474","article-title":"Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation","volume":"21","author":"Callemeyn","year":"2021","journal-title":"Am J Transplant"},{"key":"2026102205030484200_bib7","doi-asserted-by":"publisher","first-page":"13209","DOI":"10.3389\/ti.2024.13209","article-title":"Natural killer cell presence in antibody-mediated rejection","volume":"37","author":"Diebold","year":"2024","journal-title":"Transpl Int"},{"key":"2026102205030484200_bib8","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","article-title":"NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection","volume":"10","author":"Hidalgo","year":"2010","journal-title":"Am J Transplant"},{"key":"2026102205030484200_bib9","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1681\/ASN.2020030306","article-title":"Transcriptional changes in kidney allografts with histology of antibody-mediated rejection without anti-HLA donor-specific antibodies","volume":"31","author":"Callemeyn","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2026102205030484200_bib10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.coi.2012.01.001","article-title":"NK cell MHC class I specific receptors (KIR): from biology to clinical intervention","volume":"24","author":"Thielens","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"2026102205030484200_bib11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1681\/ASN.2020040433","article-title":"Missing self-induced activation of NK cells combines with non-complement-fixing donor-specific antibodies to accelerate kidney transplant loss in chronic antibody-mediated rejection","volume":"32","author":"Koenig","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026102205030484200_bib12","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1002\/eji.201444515","article-title":"Fc\u03b3RIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and Fc\u03b3RII (CD32)","volume":"44","author":"Bhatnagar","year":"2014","journal-title":"Eur J Immunol"},{"key":"2026102205030484200_bib13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1158\/0008-5472.CAN-05-2776","article-title":"Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance","volume":"66","author":"Hayashi","year":"2006","journal-title":"Cancer Res"},{"key":"2026102205030484200_bib14","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.humimm.2015.09.003","article-title":"HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire","volume":"76","author":"Lauterbach","year":"2015","journal-title":"Hum Immunol"},{"key":"2026102205030484200_bib15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ajt.2023.12.005","article-title":"Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation","volume":"24","author":"Diebold","year":"2024","journal-title":"Am J Transplant"},{"key":"2026102205030484200_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/TP.0000000000005228","article-title":"Functional natural killer-cell genetics and microvascular inflammation after kidney transplantation: an observational cohort study","volume":"109","author":"Diebold","year":"2025","journal-title":"Transplantation"},{"key":"2026102205030484200_bib17","doi-asserted-by":"publisher","first-page":"7903","DOI":"10.1038\/s41598-021-86943-3","article-title":"The FCGR3A 158 V\/V-genotype is associated with decreased survival of renal allografts with chronic active antibody-mediated rejection","volume":"11","author":"Litjens","year":"2021","journal-title":"Sci Rep"},{"key":"2026102205030484200_bib18","doi-asserted-by":"publisher","first-page":"724331","DOI":"10.3389\/fimmu.2021.724331","article-title":"Functional Fc gamma receptor gene polymorphisms and long-term kidney allograft survival","volume":"12","author":"Wahrmann","year":"2021","journal-title":"Front Immunol"},{"key":"2026102205030484200_bib19","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/ajt.14710","article-title":"Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation","volume":"18","author":"Arnold","year":"2018","journal-title":"Am J Transplant"},{"key":"2026102205030484200_bib20","doi-asserted-by":"crossref","first-page":"829228","DOI":"10.3389\/fimmu.2022.829228","article-title":"Deletion of the natural killer cell receptor NKG2C encoding KLR2C gene and kidney transplant outcome","volume":"13","author":"Vietzen","year":"2022","journal-title":"Front Immunol"},{"key":"2026102205030484200_bib21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1600-6143.2008.02526.x","article-title":"Potential role of NKG2D and its ligands in organ transplantation: new target for immunointervention","volume":"9","author":"Su\u00e1rez-\u00c1lvarez","year":"2009","journal-title":"Am J Transplant"},{"key":"2026102205030484200_bib22","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.4049\/jimmunol.1102775","article-title":"A 17q12 allele is associated with altered NK cell subsets and function","volume":"188","author":"Xia","year":"2012","journal-title":"J Immunol"},{"key":"2026102205030484200_bib23","doi-asserted-by":"publisher","DOI":"10.3791\/61971","article-title":"TBase\u2014an integrated electronic health record and research database for kidney transplant recipients","author":"Schmidt","year":"2021","journal-title":"J Vis Exp"},{"key":"2026102205030484200_bib24","doi-asserted-by":"publisher","first-page":"943502","DOI":"10.3389\/fmed.2022.943502","article-title":"The natural history of de novo donor-specific HLA antibodies after kidney transplantation","volume":"9","author":"L\u00f3pez\u00a0del\u00a0Moral","year":"2022","journal-title":"Front Med"},{"key":"2026102205030484200_bib25","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"},{"key":"2026102205030484200_bib26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"2026102205030484200_bib27","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.humimm.2013.06.025","article-title":"Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry","volume":"74","author":"Gragert","year":"2013","journal-title":"Hum Immunol"},{"key":"2026102205030484200_bib28","doi-asserted-by":"crossref","first-page":"1352764","DOI":"10.3389\/fgene.2024.1352764","article-title":"Advancing precision in histocompatibility and immunogenetics: a comprehensive review of the UCLA exchange program","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Genet"},{"key":"2026102205030484200_bib29","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"key":"2026102205030484200_bib30","doi-asserted-by":"publisher","first-page":"e28404","DOI":"10.1002\/jmv.28404","article-title":"The natural killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19","volume":"95","author":"Vietzen","year":"2023","journal-title":"J Med Virol"},{"key":"2026102205030484200_bib31","article-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2025"},{"key":"2026102205030484200_bib32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"2026102205030484200_bib33","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2307\/2530047","article-title":"Covariance adjustment of relative-risk estimates in matched studies","volume":"38","author":"Breslow","year":"1982","journal-title":"Biometrics"},{"key":"2026102205030484200_bib34","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/sim.3057","article-title":"Sample size evaluation for a multiply matched case-control study using the score test from a conditional logistic (discrete Cox PH) regression model","volume":"27","author":"Lachin","year":"2008","journal-title":"Stat Med"},{"key":"2026102205030484200_bib35","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/01.tp.0000286097.11173.70","article-title":"KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation","volume":"84","author":"Kreijveld","year":"2007","journal-title":"Transplantation"},{"key":"2026102205030484200_bib36","doi-asserted-by":"publisher","first-page":"e23631","DOI":"10.1371\/journal.pone.0023631","article-title":"KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation","volume":"6","author":"Hanvesakul","year":"2011","journal-title":"PLoS One"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag231\/71665308\/gfag231.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag231\/71665308\/gfag231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:03:13Z","timestamp":1792659793000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article\/doi\/10.1093\/ndt\/gfag231\/8875678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag231","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"gfag231"}}